Company intelligence / Profile preview

Olon USA

Concord, Ohio, United Statesolon-usa.com ↗

Ownership: Private
Employees: ~160
Development stage: Commercial

Overview

Provides integrated chemical synthesis and biological processing services for pharmaceutical development and manufacturing. No proprietary clinical results as it operates as a service provider. Passed >200 client audits and US FDA inspections since first PAI in 2004. Merged into "Olon USA" in January 2024 to further integrate with the global Olon Group network. Significant investments ongoing to expand capacity at Concord site. Known for strong compliance record and repeat business from major pharma/biotech clients.

Modalities: Small moleculeBiologic (via microbial fermentation)Specialty chemicalsAdvanced intermediatesReference standardsMetabolites and impurities
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Olon USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olon USA.

Explore the full profile